FDA
-
-
-
-
-
-
-
Grifols' (GRFS) anti-SARS-CoV-2 hyperimmune globulin begins clinical trial in patients with COVID-19
-
-
-
-
-
-
-
People Who Have Recovered from COVID-19 Can Now Donate their Convalescent Plasma in select Grifols U.S. Plasma Donor Centers
-
-
-
-
-
-
-
Grifols (GRFS) Announces FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System
-
-
-
-
-
-
-
Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System
-
-
-
-
323,899 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

